Innate Pharma SA (IPHA)
1.54
+0.06
(+4.05%)
USD |
NASDAQ |
Oct 09, 11:21
Innate Pharma Max Drawdown (5Y) : 85.56% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 85.56% |
| August 31, 2026 | 85.56% |
| July 31, 2026 | 85.56% |
| June 30, 2026 | 85.56% |
| May 31, 2026 | 85.56% |
| April 30, 2026 | 85.56% |
| March 31, 2026 | 85.56% |
| February 28, 2026 | 82.44% |
| January 31, 2026 | 82.44% |
| December 31, 2025 | 82.44% |
| November 30, 2025 | 82.44% |
| October 31, 2025 | 82.44% |
| September 30, 2025 | 82.44% |
| August 31, 2025 | 82.44% |
| July 31, 2025 | 82.44% |
| June 30, 2025 | 82.44% |
| May 31, 2025 | 82.44% |
| April 30, 2025 | 82.44% |
| March 31, 2025 | 82.44% |
| February 28, 2025 | 82.44% |
| January 31, 2025 | 82.44% |
| December 31, 2024 | 82.44% |
| November 30, 2024 | 82.44% |
| October 31, 2024 | 79.15% |
| September 30, 2024 | 76.83% |
| Date | Value |
|---|---|
| August 31, 2024 | 76.83% |
| July 31, 2024 | 76.83% |
| June 30, 2024 | 76.83% |
| May 31, 2024 | 76.83% |
| April 30, 2024 | 76.83% |
| March 31, 2024 | 76.83% |
| February 29, 2024 | 76.83% |
| January 31, 2024 | 76.83% |
| December 31, 2023 | 76.83% |
| November 30, 2023 | 76.83% |
| October 31, 2023 | 76.83% |
| September 30, 2023 | 76.83% |
| August 31, 2023 | 76.83% |
| July 31, 2023 | 76.83% |
| June 30, 2023 | 76.83% |
| May 31, 2023 | 76.83% |
| April 30, 2023 | 76.83% |
| March 31, 2023 | 76.83% |
| February 28, 2023 | 76.83% |
| January 31, 2023 | 76.83% |
| December 31, 2022 | 76.83% |
| November 30, 2022 | 75.61% |
| October 31, 2022 | 75.61% |
| September 30, 2022 | 75.61% |
| August 31, 2022 | 75.61% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Nicox SA | 96.28% |
| DBV Technologies SA | 98.19% |
| Cellectis SA | 97.08% |
| Genfit SA | 90.85% |
| Inventiva SA | 91.32% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.35 |
| Beta (5Y) | 0.7189 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.83% |
| Historical Sharpe Ratio (5Y) | -0.4953 |
| Historical Sortino (5Y) | -1.006 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 22.53% |